[PDF][PDF] One year in review 2017: novelties in the treatment of rheumatoid arthritis

F Ferro, E Elefante, N Luciano, R Talarico… - Clin Exp …, 2017 - clinexprheumatol.org
Rheumatoid arthritis (RA) is a chronic disease characterised by inflammation of the synovial
tissue in joints, which can lead to joint destruction. The primary goal of the treatment is to …

Evolving short-and long-term goals of management of inflammatory bowel diseases: getting it right, making it last

C Le Berre, A Ricciuto, L Peyrin-Biroulet, D Turner - Gastroenterology, 2022 - Elsevier
Short-and long-term treatment targets in inflammatory bowel diseases (IBDs) evolved during
the last decade, shifting from symptom control to endoscopic healing and patient-centered …

Can we change the natural course of inflammatory bowel disease?

C Le Berre, S Danese… - Therapeutic Advances …, 2023 - journals.sagepub.com
Inflammatory bowel diseases (IBD), including Crohn's disease (CD) and ulcerative colitis
(UC), are lifelong diseases characterized by chronic inflammation of the gastrointestinal tract …

Systemic manifestations of primary Sjögren's syndrome in the NOD. B10Sn-H2b/J mouse model

J Kiripolsky, L Shen, Y Liang, A Li, L Suresh, Y Lian… - Clinical …, 2017 - Elsevier
Animal models that recapitulate human disease are crucial for the study of Sjögren's
Syndrome (SS). While several SS mouse models exist, there are few primary SS (pSS) …

[PDF][PDF] In early arthritis patients, high HAQ at baseline and DAS28 at three months predict suboptimal outcomes at two years: a retrospective cohort study

A Fanouriakis, I Papalopoulos, I Gergianaki… - Clin Exp …, 2018 - clinexprheumatol.org
Objective Early arthritis clinics (EAC) aim to improve rheumatoid arthritis (RA) outcomes by
tailoring treatment targeting to remission. Our aim was to analyse disease course and …

Efficacy of methotrexate and etanercept biosimilar rhTNFR: Fc in Chinese patients with active rheumatoid arthritis: A controlled, randomized and multicenter study

Q Wu, Y Zhao, D Xu, Z Zhang, Z Li - Scientific Reports, 2020 - nature.com
Rheumatoid arthritis is a chronic inflammatory disease which could lead to severe joint
damage and disability. This study was performed to determine the efficacy and safety of …

[HTML][HTML] An update on research advances in rheumatoid arthritis: from clinic to basic science

E Corsiero, A Marrelli - Journal of Laboratory and Precision …, 2018 - jlpm.amegroups.org
Rheumatoid arthritis (RA) is a chronic inflammatory autoimmune disease characterised by
breach of self-tolerance and production of autoantibodies, particularly rheumatoid factor …

Association among anti-citrullinated protein antibody status, erosive disease and healthcare resource utilization in patients with rheumatoid arthritis

LR Harrold, Y Shan, SE Connolly… - Current Medical …, 2020 - Taylor & Francis
Objective: To characterize the rate of healthcare resource utilization (HCRU) between anti-
cyclic citrullinated peptide (CCP; a surrogate for anti-citrullinated protein antibodies …

Early Targeted Combination Treatment With Conventional Synthetic Disease‐Modifying Antirheumatic Drugs and Long‐Term Outcomes in Rheumatoid Arthritis: Ten …

V Rantalaiho, T Sandström, J Koski… - Arthritis Care & …, 2019 - Wiley Online Library
Objective The short‐term outcomes of remission‐targeted treatments of rheumatoid arthritis
(RA) are well‐established, but the long‐term success of such strategies is speculative, as is …

Predicting and Monitoring Disease Course in Rheumatoid Arthritis: Imaging, Biomarkers, Risk Factors, and Integrative Medicine

A Levitsky - 2017 - search.proquest.com
Rheumatoid arthritis (RA), the most common inflammatory arthritis, is a chronic, potentially
debilitating autoimmune disease that can lead to functional disability, bone erosion, and …